Graziella Bellone
Department of Clinical Physiopathology
University of Turin
I-10126 Torino
Italy
Name/email consistency: high
- Abnormal expression of Endoglin and its receptor complex (TGF-β1 and TGF-β receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa. Bellone, G., Gramigni, C., Vizio, B., Mauri, F.A., Prati, A., Solerio, D., Dughera, L., Ruffini, E., Gasparri, G., Camandona, M. Int. J. Oncol. (2010)
- Impact of surgery and chemotherapy on cellular immunity in pancreatic carcinoma patients in view of an integration of standard cancer treatment with immunotherapy. Bellone, G., Novarino, A., Vizio, B., Brondino, G., Addeo, A., Prati, A., Giacobino, A., Campra, D., Fronda, G.R., Ciuffreda, L. Int. J. Oncol. (2009)
- Osteo-promoting activity of OSTEOPLANT ANGIOSTAD in vitro. Bellone, G., Scirelli, T., Emanuelli, G. Minerva. Stomatol (2008)
- Transforming growth factor-beta binding receptor endoglin (CD105) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence. Bellone, G., Solerio, D., Chiusa, L., Brondino, G., Carbone, A., Prati, A., Scirelli, T., Camandona, M., Palestro, G., Dei Poli, M. Ann. Surg. Oncol. (2007)
- Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival. Bellone, G., Smirne, C., Mauri, F.A., Tonel, E., Carbone, A., Buffolino, A., Dughera, L., Robecchi, A., Pirisi, M., Emanuelli, G. Cancer Immunol. Immunother. (2006)
- Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted by pancreatic carcinoma cells. Bellone, G., Carbone, A., Smirne, C., Scirelli, T., Buffolino, A., Novarino, A., Stacchini, A., Bertetto, O., Palestro, G., Sorio, C., Scarpa, A., Emanuelli, G., Rodeck, U. J. Immunol. (2006)
- Antagonistic interactions between gemcitabine and 5-fluorouracil in the human pancreatic carcinoma cell line Capan-2. Bellone, G., Carbone, A., Busso, V., Scirelli, T., Buffolino, A., Smirne, C., Novarino, A., Bertetto, O., Tosetti, L., Emanuelli, G. Cancer Biol. Ther. (2006)
- KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes. Bellone, G., Smirne, C., Carbone, A., Buffolino, A., Scirelli, T., Prati, A., Solerio, D., Pirisi, M., Valente, G., Nano, M., Emanuelli, G. Int. J. Oncol. (2006)
- Circulating vascular endothelial growth factor and interferon-gamma-inducible protein-10 levels in pancreatic cancer during chemotherapy. Bellone, G., Novarino, A., Chiappino, I., Gramigni, C., Carbone, A., Addeo, A., Tonel, E., Bertetto, O., Emanuelli, G. Anticancer Res. (2005)
- Inhibition of cell survival and invasive potential of colorectal carcinoma cells by the tyrosine kinase inhibitor STI571. Bellone, G., Ferrero, D., Carbone, A., De Quadros, M.R., Gramigni, C., Prati, A., Davidson, W., Mioli, P., Dughera, L., Emanuelli, G., Rodeck, U. Cancer Biol. Ther. (2004)
- Differential expression of transforming growth factors-beta1, -beta2 and -beta3 in human colon carcinoma. Bellone, G., Carbone, A., Tibaudi, D., Mauri, F., Ferrero, I., Smirne, C., Suman, F., Rivetti, C., Migliaretti, G., Camandona, M., Palestro, G., Emanuelli, G., Rodeck, U. Eur. J. Cancer (2001)
- Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential. Bellone, G., Carbone, A., Sibona, N., Bosco, O., Tibaudi, D., Smirne, C., Martone, T., Gramigni, C., Camandona, M., Emanuelli, G., Rodeck, U. Cancer Res. (2001)
